Found 75 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131874
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-Gly-Cys]-Pro-Pr...)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C74H99N19O17S2/c1-41(94)48-38-111-112-39-57(73(110)93-26-10-18-59(93)62(97)37-92-25-9-17-58(92)61(96)35-82-50(15-6-7-23-75)60(95)34-83-53(66(76)103)31-65(101)102)86-63(98)36-84-68(105)55(29-45-32-81-49-14-5-4-13-47(45)49)90-69(106)51(16-8-24-80-74(77)78)88-71(108)54(28-42-19-20-43-11-2-3-12-44(43)27-42)89-72(109)56(30-46-33-79-40-85-46)91-70(107)52(87-67(48)104)21-22-64(99)100/h2-5,11-14,19-20,27,32-33,40,48,50-59,81-83H,6-10,15-18,21-26,28-31,34-39,75H2,1H3,(H2,76,103)(H,79,85)(H,84,105)(H,86,98)(H,87,104)(H,88,108)(H,89,109)(H,90,106)(H,91,107)(H,99,100)(H,101,102)(H4,77,78,80)/t48-,50-,51-,52+,53-,54-,55+,56-,57-,58-,59-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibitory activity against human melanocortin receptor human Melanocortin 4 receptor was determined |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131874
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-Gly-Cys]-Pro-Pr...)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C74H99N19O17S2/c1-41(94)48-38-111-112-39-57(73(110)93-26-10-18-59(93)62(97)37-92-25-9-17-58(92)61(96)35-82-50(15-6-7-23-75)60(95)34-83-53(66(76)103)31-65(101)102)86-63(98)36-84-68(105)55(29-45-32-81-49-14-5-4-13-47(45)49)90-69(106)51(16-8-24-80-74(77)78)88-71(108)54(28-42-19-20-43-11-2-3-12-44(43)27-42)89-72(109)56(30-46-33-79-40-85-46)91-70(107)52(87-67(48)104)21-22-64(99)100/h2-5,11-14,19-20,27,32-33,40,48,50-59,81-83H,6-10,15-18,21-26,28-31,34-39,75H2,1H3,(H2,76,103)(H,79,85)(H,84,105)(H,86,98)(H,87,104)(H,88,108)(H,89,109)(H,90,106)(H,91,107)(H,99,100)(H,101,102)(H4,77,78,80)/t48-,50-,51-,52+,53-,54-,55+,56-,57-,58-,59-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 54 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibitory activity against human Melanocortin 3 receptor was determined |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131874
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-Gly-Cys]-Pro-Pr...)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C74H99N19O17S2/c1-41(94)48-38-111-112-39-57(73(110)93-26-10-18-59(93)62(97)37-92-25-9-17-58(92)61(96)35-82-50(15-6-7-23-75)60(95)34-83-53(66(76)103)31-65(101)102)86-63(98)36-84-68(105)55(29-45-32-81-49-14-5-4-13-47(45)49)90-69(106)51(16-8-24-80-74(77)78)88-71(108)54(28-42-19-20-43-11-2-3-12-44(43)27-42)89-72(109)56(30-46-33-79-40-85-46)91-70(107)52(87-67(48)104)21-22-64(99)100/h2-5,11-14,19-20,27,32-33,40,48,50-59,81-83H,6-10,15-18,21-26,28-31,34-39,75H2,1H3,(H2,76,103)(H,79,85)(H,84,105)(H,86,98)(H,87,104)(H,88,108)(H,89,109)(H,90,106)(H,91,107)(H,99,100)(H,101,102)(H4,77,78,80)/t48-,50-,51-,52+,53-,54-,55+,56-,57-,58-,59-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 649 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibitory activity against human melanocortin receptor human Melanocortin 5 receptor was determined |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM82411
(CAS_75921-69-6 | NDP-MSH)Show SMILES CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O |r,wU:66.68,55.56,45.45,111.116,4.4,14.23,wD:77.79,95.99,107.113,36.36,8.10,26.29,(-7.66,4.36,;-8.98,3.65,;-9.15,2.12,;-10.5,1.37,;-10.5,-.23,;-11.93,-.94,;-13.21,-.15,;-13.17,1.41,;-14.6,-.83,;-14.64,-2.37,;-13.43,-3.18,;-15.78,-.09,;-17.19,-.68,;-17.34,-2.22,;-18.55,.02,;-18.4,1.67,;-17.08,2.44,;-17.08,3.97,;-15.61,4.72,;-14.35,3.82,;-13,4.55,;-14.45,2.26,;-15.78,1.52,;-19.9,-.62,;-21.14,.17,;-21.14,1.73,;-22.53,-.62,;-22.53,-2.12,;-21.33,-2.88,;-23.81,.17,;-25.13,-.41,;-26.27,.45,;-25.2,-1.9,;-9.26,-1,;-9.3,-2.5,;-7.94,-.34,;-6.59,-1.15,;-6.59,-2.71,;-7.94,-3.46,;-7.94,-5,;-9.3,-5.6,;-6.63,-5.81,;-5.24,-.34,;-5.2,1.15,;-3.86,-1.11,;-2.57,-.23,;-2.57,1.26,;-1.19,2.05,;.1,1.47,;1.29,2.58,;.52,3.87,;-.97,3.65,;-1.19,-1,;-1.19,-2.5,;.1,-.3,;1.55,-1.15,;1.55,-2.65,;2.79,-3.4,;2.79,-4.89,;4.22,-5.7,;5.56,-4.89,;5.56,-3.4,;4.22,-2.65,;2.79,-.34,;2.79,1.2,;4.22,-1,;5.33,-.09,;5.29,1.47,;6.63,2.26,;6.53,3.82,;7.81,4.72,;7.81,6.13,;9.13,7.03,;6.46,6.92,;6.85,-.73,;7,-2.37,;8,.13,;9.35,-.41,;9.69,-2.07,;10.95,-2.71,;12.29,-1.9,;13.51,-2.99,;12.83,-4.36,;13.43,-5.81,;12.55,-7.03,;10.95,-6.77,;10.33,-5.43,;11.29,-4.21,;10.69,.41,;10.48,2.16,;12.04,-.41,;13.38,.3,;14.58,-.51,;14.47,-2.03,;15.99,.17,;17.25,-.68,;17.25,-2.26,;18.49,-3.08,;18.45,-4.57,;19.73,-5.55,;19.69,-7.03,;18.66,.02,;18.77,1.52,;20.01,-.68,;20.09,-2.22,;21.72,-2.54,;22.29,-1.11,;21.5,-.09,;21.78,1.47,;20.65,2.84,;23.32,1.64,;23.83,2.97,;23,4.19,;23.6,5.58,;21.5,4.04,;25.41,3.12,;26.03,4.44,;26.27,1.94,)| Show InChI InChI=1S/C78H111N21O19/c1-5-6-19-52(91-75(116)61(41-101)97-72(113)57(34-46-24-26-49(103)27-25-46)94-74(115)60(40-100)88-44(4)102)68(109)92-54(28-29-64(105)106)70(111)96-59(36-48-38-83-42-87-48)73(114)93-56(33-45-16-8-7-9-17-45)71(112)90-53(22-14-31-84-78(81)82)69(110)95-58(35-47-37-85-51-20-11-10-18-50(47)51)67(108)86-39-63(104)89-55(21-12-13-30-79)77(118)99-32-15-23-62(99)76(117)98-65(43(2)3)66(80)107/h7-11,16-18,20,24-27,37-38,42-43,52-62,65,85,100-101,103H,5-6,12-15,19,21-23,28-36,39-41,79H2,1-4H3,(H2,80,107)(H,83,87)(H,86,108)(H,88,102)(H,89,104)(H,90,112)(H,91,116)(H,92,109)(H,93,114)(H,94,115)(H,95,110)(H,96,111)(H,97,113)(H,98,117)(H,105,106)(H4,81,82,84)/t52-,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,65-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM82411
(CAS_75921-69-6 | NDP-MSH)Show SMILES CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O |r,wU:66.68,55.56,45.45,111.116,4.4,14.23,wD:77.79,95.99,107.113,36.36,8.10,26.29,(-7.66,4.36,;-8.98,3.65,;-9.15,2.12,;-10.5,1.37,;-10.5,-.23,;-11.93,-.94,;-13.21,-.15,;-13.17,1.41,;-14.6,-.83,;-14.64,-2.37,;-13.43,-3.18,;-15.78,-.09,;-17.19,-.68,;-17.34,-2.22,;-18.55,.02,;-18.4,1.67,;-17.08,2.44,;-17.08,3.97,;-15.61,4.72,;-14.35,3.82,;-13,4.55,;-14.45,2.26,;-15.78,1.52,;-19.9,-.62,;-21.14,.17,;-21.14,1.73,;-22.53,-.62,;-22.53,-2.12,;-21.33,-2.88,;-23.81,.17,;-25.13,-.41,;-26.27,.45,;-25.2,-1.9,;-9.26,-1,;-9.3,-2.5,;-7.94,-.34,;-6.59,-1.15,;-6.59,-2.71,;-7.94,-3.46,;-7.94,-5,;-9.3,-5.6,;-6.63,-5.81,;-5.24,-.34,;-5.2,1.15,;-3.86,-1.11,;-2.57,-.23,;-2.57,1.26,;-1.19,2.05,;.1,1.47,;1.29,2.58,;.52,3.87,;-.97,3.65,;-1.19,-1,;-1.19,-2.5,;.1,-.3,;1.55,-1.15,;1.55,-2.65,;2.79,-3.4,;2.79,-4.89,;4.22,-5.7,;5.56,-4.89,;5.56,-3.4,;4.22,-2.65,;2.79,-.34,;2.79,1.2,;4.22,-1,;5.33,-.09,;5.29,1.47,;6.63,2.26,;6.53,3.82,;7.81,4.72,;7.81,6.13,;9.13,7.03,;6.46,6.92,;6.85,-.73,;7,-2.37,;8,.13,;9.35,-.41,;9.69,-2.07,;10.95,-2.71,;12.29,-1.9,;13.51,-2.99,;12.83,-4.36,;13.43,-5.81,;12.55,-7.03,;10.95,-6.77,;10.33,-5.43,;11.29,-4.21,;10.69,.41,;10.48,2.16,;12.04,-.41,;13.38,.3,;14.58,-.51,;14.47,-2.03,;15.99,.17,;17.25,-.68,;17.25,-2.26,;18.49,-3.08,;18.45,-4.57,;19.73,-5.55,;19.69,-7.03,;18.66,.02,;18.77,1.52,;20.01,-.68,;20.09,-2.22,;21.72,-2.54,;22.29,-1.11,;21.5,-.09,;21.78,1.47,;20.65,2.84,;23.32,1.64,;23.83,2.97,;23,4.19,;23.6,5.58,;21.5,4.04,;25.41,3.12,;26.03,4.44,;26.27,1.94,)| Show InChI InChI=1S/C78H111N21O19/c1-5-6-19-52(91-75(116)61(41-101)97-72(113)57(34-46-24-26-49(103)27-25-46)94-74(115)60(40-100)88-44(4)102)68(109)92-54(28-29-64(105)106)70(111)96-59(36-48-38-83-42-87-48)73(114)93-56(33-45-16-8-7-9-17-45)71(112)90-53(22-14-31-84-78(81)82)69(110)95-58(35-47-37-85-51-20-11-10-18-50(47)51)67(108)86-39-63(104)89-55(21-12-13-30-79)77(118)99-32-15-23-62(99)76(117)98-65(43(2)3)66(80)107/h7-11,16-18,20,24-27,37-38,42-43,52-62,65,85,100-101,103H,5-6,12-15,19,21-23,28-36,39-41,79H2,1-4H3,(H2,80,107)(H,83,87)(H,86,108)(H,88,102)(H,89,104)(H,90,112)(H,91,116)(H,92,109)(H,93,114)(H,94,115)(H,95,110)(H,96,111)(H,97,113)(H,98,117)(H,105,106)(H4,81,82,84)/t52-,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,65-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131880
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C74H100N18O16S2/c1-41(93)64-71(107)86-51(23-24-62(97)98)67(103)89-55(32-46-35-79-40-84-46)70(106)87-53(30-42-21-22-43-13-4-5-14-44(43)29-42)68(104)85-50(18-10-26-80-73(77)78)66(102)88-54(31-45-34-81-48-16-7-6-15-47(45)48)69(105)90-56(39-109-110-74(64,2)3)72(108)92-28-12-20-58(92)61(96)38-91-27-11-19-57(91)60(95)37-82-49(17-8-9-25-75)59(94)36-83-52(65(76)101)33-63(99)100/h4-7,13-16,21-22,29,34-35,40,49-58,64,81-83H,8-12,17-20,23-28,30-33,36-39,75H2,1-3H3,(H2,76,101)(H,79,84)(H,85,104)(H,86,107)(H,87,106)(H,88,102)(H,89,103)(H,90,105)(H,97,98)(H,99,100)(H4,77,78,80)/t49-,50-,51+,52-,53-,54+,55-,56?,57-,58-,64?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM82411
(CAS_75921-69-6 | NDP-MSH)Show SMILES CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O |r,wU:66.68,55.56,45.45,111.116,4.4,14.23,wD:77.79,95.99,107.113,36.36,8.10,26.29,(-7.66,4.36,;-8.98,3.65,;-9.15,2.12,;-10.5,1.37,;-10.5,-.23,;-11.93,-.94,;-13.21,-.15,;-13.17,1.41,;-14.6,-.83,;-14.64,-2.37,;-13.43,-3.18,;-15.78,-.09,;-17.19,-.68,;-17.34,-2.22,;-18.55,.02,;-18.4,1.67,;-17.08,2.44,;-17.08,3.97,;-15.61,4.72,;-14.35,3.82,;-13,4.55,;-14.45,2.26,;-15.78,1.52,;-19.9,-.62,;-21.14,.17,;-21.14,1.73,;-22.53,-.62,;-22.53,-2.12,;-21.33,-2.88,;-23.81,.17,;-25.13,-.41,;-26.27,.45,;-25.2,-1.9,;-9.26,-1,;-9.3,-2.5,;-7.94,-.34,;-6.59,-1.15,;-6.59,-2.71,;-7.94,-3.46,;-7.94,-5,;-9.3,-5.6,;-6.63,-5.81,;-5.24,-.34,;-5.2,1.15,;-3.86,-1.11,;-2.57,-.23,;-2.57,1.26,;-1.19,2.05,;.1,1.47,;1.29,2.58,;.52,3.87,;-.97,3.65,;-1.19,-1,;-1.19,-2.5,;.1,-.3,;1.55,-1.15,;1.55,-2.65,;2.79,-3.4,;2.79,-4.89,;4.22,-5.7,;5.56,-4.89,;5.56,-3.4,;4.22,-2.65,;2.79,-.34,;2.79,1.2,;4.22,-1,;5.33,-.09,;5.29,1.47,;6.63,2.26,;6.53,3.82,;7.81,4.72,;7.81,6.13,;9.13,7.03,;6.46,6.92,;6.85,-.73,;7,-2.37,;8,.13,;9.35,-.41,;9.69,-2.07,;10.95,-2.71,;12.29,-1.9,;13.51,-2.99,;12.83,-4.36,;13.43,-5.81,;12.55,-7.03,;10.95,-6.77,;10.33,-5.43,;11.29,-4.21,;10.69,.41,;10.48,2.16,;12.04,-.41,;13.38,.3,;14.58,-.51,;14.47,-2.03,;15.99,.17,;17.25,-.68,;17.25,-2.26,;18.49,-3.08,;18.45,-4.57,;19.73,-5.55,;19.69,-7.03,;18.66,.02,;18.77,1.52,;20.01,-.68,;20.09,-2.22,;21.72,-2.54,;22.29,-1.11,;21.5,-.09,;21.78,1.47,;20.65,2.84,;23.32,1.64,;23.83,2.97,;23,4.19,;23.6,5.58,;21.5,4.04,;25.41,3.12,;26.03,4.44,;26.27,1.94,)| Show InChI InChI=1S/C78H111N21O19/c1-5-6-19-52(91-75(116)61(41-101)97-72(113)57(34-46-24-26-49(103)27-25-46)94-74(115)60(40-100)88-44(4)102)68(109)92-54(28-29-64(105)106)70(111)96-59(36-48-38-83-42-87-48)73(114)93-56(33-45-16-8-7-9-17-45)71(112)90-53(22-14-31-84-78(81)82)69(110)95-58(35-47-37-85-51-20-11-10-18-50(47)51)67(108)86-39-63(104)89-55(21-12-13-30-79)77(118)99-32-15-23-62(99)76(117)98-65(43(2)3)66(80)107/h7-11,16-18,20,24-27,37-38,42-43,52-62,65,85,100-101,103H,5-6,12-15,19,21-23,28-36,39-41,79H2,1-4H3,(H2,80,107)(H,83,87)(H,86,108)(H,88,102)(H,89,104)(H,90,112)(H,91,116)(H,92,109)(H,93,114)(H,94,115)(H,95,110)(H,96,111)(H,97,113)(H,98,117)(H,105,106)(H4,81,82,84)/t52-,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,65-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50001520
(CHEMBL2111807)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:100.108,85.93,52.56,3.2,37.39,26.28,wD:8.76,77.84,12.12,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49-,50-,51+,52-,53-,54+,55-,56-,57-,58-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50029747
((4S)-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-[({[(2S...)Show SMILES CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O Show InChI InChI=1S/C77H109N21O19S/c1-42(2)64(65(79)106)97-75(116)61-20-13-30-98(61)76(117)54(18-10-11-28-78)88-62(103)38-85-66(107)57(34-46-36-84-50-17-9-8-16-49(46)50)94-67(108)51(19-12-29-83-77(80)81)89-70(111)55(32-44-14-6-5-7-15-44)92-72(113)58(35-47-37-82-41-86-47)95-68(109)52(25-26-63(104)105)90-69(110)53(27-31-118-4)91-74(115)60(40-100)96-71(112)56(33-45-21-23-48(102)24-22-45)93-73(114)59(39-99)87-43(3)101/h5-9,14-17,21-24,36-37,41-42,51-61,64,84,99-100,102H,10-13,18-20,25-35,38-40,78H2,1-4H3,(H2,79,106)(H,82,86)(H,85,107)(H,87,101)(H,88,103)(H,89,111)(H,90,110)(H,91,115)(H,92,113)(H,93,114)(H,94,108)(H,95,109)(H,96,112)(H,97,116)(H,104,105)(H4,80,81,83)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,64-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50001519
(CHEMBL2111808)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:96.103,81.88,48.51,3.2,37.39,26.28,wD:8.71,73.79,12.12,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45-,46-,47+,48-,49-,50+,51-,52-,53-,54-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50029747
((4S)-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-[({[(2S...)Show SMILES CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O Show InChI InChI=1S/C77H109N21O19S/c1-42(2)64(65(79)106)97-75(116)61-20-13-30-98(61)76(117)54(18-10-11-28-78)88-62(103)38-85-66(107)57(34-46-36-84-50-17-9-8-16-49(46)50)94-67(108)51(19-12-29-83-77(80)81)89-70(111)55(32-44-14-6-5-7-15-44)92-72(113)58(35-47-37-82-41-86-47)95-68(109)52(25-26-63(104)105)90-69(110)53(27-31-118-4)91-74(115)60(40-100)96-71(112)56(33-45-21-23-48(102)24-22-45)93-73(114)59(39-99)87-43(3)101/h5-9,14-17,21-24,36-37,41-42,51-61,64,84,99-100,102H,10-13,18-20,25-35,38-40,78H2,1-4H3,(H2,79,106)(H,82,86)(H,85,107)(H,87,101)(H,88,103)(H,89,111)(H,90,110)(H,91,115)(H,92,113)(H,93,114)(H,94,108)(H,95,109)(H,96,112)(H,97,116)(H,104,105)(H4,80,81,83)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,64-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50029747
((4S)-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-[({[(2S...)Show SMILES CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O Show InChI InChI=1S/C77H109N21O19S/c1-42(2)64(65(79)106)97-75(116)61-20-13-30-98(61)76(117)54(18-10-11-28-78)88-62(103)38-85-66(107)57(34-46-36-84-50-17-9-8-16-49(46)50)94-67(108)51(19-12-29-83-77(80)81)89-70(111)55(32-44-14-6-5-7-15-44)92-72(113)58(35-47-37-82-41-86-47)95-68(109)52(25-26-63(104)105)90-69(110)53(27-31-118-4)91-74(115)60(40-100)96-71(112)56(33-45-21-23-48(102)24-22-45)93-73(114)59(39-99)87-43(3)101/h5-9,14-17,21-24,36-37,41-42,51-61,64,84,99-100,102H,10-13,18-20,25-35,38-40,78H2,1-4H3,(H2,79,106)(H,82,86)(H,85,107)(H,87,101)(H,88,103)(H,89,111)(H,90,110)(H,91,115)(H,92,113)(H,93,114)(H,94,108)(H,95,109)(H,96,112)(H,97,116)(H,104,105)(H4,80,81,83)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,64-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131877
(Ac-c[Cys-Glu-Pro-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C71H96N16O16S2/c1-40(88)46-38-104-105-39-54(70(103)86-28-10-19-56(86)60(91)37-85-27-9-18-55(85)59(90)36-78-48(16-6-7-25-72)58(89)35-79-51(63(73)96)33-62(94)95)84-67(100)53(32-44-34-77-47-15-5-4-14-45(44)47)82-65(98)49(17-8-26-76-71(74)75)80-66(99)52(31-41-21-22-42-12-2-3-13-43(42)30-41)83-68(101)57-20-11-29-87(57)69(102)50(81-64(46)97)23-24-61(92)93/h2-5,12-15,21-22,30,34,46,48-57,77-79H,6-11,16-20,23-29,31-33,35-39,72H2,1H3,(H2,73,96)(H,80,99)(H,81,97)(H,82,98)(H,83,101)(H,84,100)(H,92,93)(H,94,95)(H4,74,75,76)/t46-,48-,49-,50+,51-,52-,53+,54+,55-,56-,57-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50001505
(CHEMBL2112604)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.71,96.103,81.88,48.51,37.39,26.28,wD:73.79,12.12,3.2,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45+,46+,47-,48+,49+,50-,51+,52-,53+,54+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 73 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131880
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C74H100N18O16S2/c1-41(93)64-71(107)86-51(23-24-62(97)98)67(103)89-55(32-46-35-79-40-84-46)70(106)87-53(30-42-21-22-43-13-4-5-14-44(43)29-42)68(104)85-50(18-10-26-80-73(77)78)66(102)88-54(31-45-34-81-48-16-7-6-15-47(45)48)69(105)90-56(39-109-110-74(64,2)3)72(108)92-28-12-20-58(92)61(96)38-91-27-11-19-57(91)60(95)37-82-49(17-8-9-25-75)59(94)36-83-52(65(76)101)33-63(99)100/h4-7,13-16,21-22,29,34-35,40,49-58,64,81-83H,8-12,17-20,23-28,30-33,36-39,75H2,1-3H3,(H2,76,101)(H,79,84)(H,85,104)(H,86,107)(H,87,106)(H,88,102)(H,89,103)(H,90,105)(H,97,98)(H,99,100)(H4,77,78,80)/t49-,50-,51+,52-,53-,54+,55-,56?,57-,58-,64?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 94 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50001520
(CHEMBL2111807)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:100.108,85.93,52.56,3.2,37.39,26.28,wD:8.76,77.84,12.12,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49-,50-,51+,52-,53-,54+,55-,56-,57-,58-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50001520
(CHEMBL2111807)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:100.108,85.93,52.56,3.2,37.39,26.28,wD:8.76,77.84,12.12,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49-,50-,51+,52-,53-,54+,55-,56-,57-,58-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50001518
(CHEMBL2112603)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.76,100.108,85.93,52.56,37.39,26.28,wD:77.84,12.12,3.2,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49+,50+,51-,52+,53+,54-,55+,56-,57+,58+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131881
(Ac-c[Cys-Glu-Pro-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C67H94N16O16S2/c1-38(84)42-36-100-101-37-50(66(99)82-27-11-20-52(82)56(87)35-81-26-10-19-51(81)55(86)34-74-44(17-7-8-24-68)54(85)33-75-47(59(69)92)31-58(90)91)80-63(96)49(30-40-32-73-43-16-6-5-15-41(40)43)78-61(94)45(18-9-25-72-67(70)71)76-62(95)48(29-39-13-3-2-4-14-39)79-64(97)53-21-12-28-83(53)65(98)46(77-60(42)93)22-23-57(88)89/h2-6,13-16,32,42,44-53,73-75H,7-12,17-31,33-37,68H2,1H3,(H2,69,92)(H,76,95)(H,77,93)(H,78,94)(H,79,97)(H,80,96)(H,88,89)(H,90,91)(H4,70,71,72)/t42-,44-,45-,46+,47-,48-,49+,50+,51-,52-,53-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131875
(Ac-c[Pen-Glu-His-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C70H98N18O16S2/c1-39(89)60-67(103)82-47(22-23-58(93)94)63(99)85-51(30-42-33-75-38-80-42)66(102)83-49(28-40-14-5-4-6-15-40)64(100)81-46(19-11-25-76-69(73)74)62(98)84-50(29-41-32-77-44-17-8-7-16-43(41)44)65(101)86-52(37-105-106-70(60,2)3)68(104)88-27-13-21-54(88)57(92)36-87-26-12-20-53(87)56(91)35-78-45(18-9-10-24-71)55(90)34-79-48(61(72)97)31-59(95)96/h4-8,14-17,32-33,38,45-54,60,77-79H,9-13,18-31,34-37,71H2,1-3H3,(H2,72,97)(H,75,80)(H,81,100)(H,82,103)(H,83,102)(H,84,98)(H,85,99)(H,86,101)(H,93,94)(H,95,96)(H4,73,74,76)/t45-,46-,47+,48-,49-,50+,51-,52?,53-,54-,60?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 430 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50001505
(CHEMBL2112604)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.71,96.103,81.88,48.51,37.39,26.28,wD:73.79,12.12,3.2,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45+,46+,47-,48+,49+,50-,51+,52-,53+,54+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 620 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131880
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C74H100N18O16S2/c1-41(93)64-71(107)86-51(23-24-62(97)98)67(103)89-55(32-46-35-79-40-84-46)70(106)87-53(30-42-21-22-43-13-4-5-14-44(43)29-42)68(104)85-50(18-10-26-80-73(77)78)66(102)88-54(31-45-34-81-48-16-7-6-15-47(45)48)69(105)90-56(39-109-110-74(64,2)3)72(108)92-28-12-20-58(92)61(96)38-91-27-11-19-57(91)60(95)37-82-49(17-8-9-25-75)59(94)36-83-52(65(76)101)33-63(99)100/h4-7,13-16,21-22,29,34-35,40,49-58,64,81-83H,8-12,17-20,23-28,30-33,36-39,75H2,1-3H3,(H2,76,101)(H,79,84)(H,85,104)(H,86,107)(H,87,106)(H,88,102)(H,89,103)(H,90,105)(H,97,98)(H,99,100)(H4,77,78,80)/t49-,50-,51+,52-,53-,54+,55-,56?,57-,58-,64?/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131875
(Ac-c[Pen-Glu-His-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C70H98N18O16S2/c1-39(89)60-67(103)82-47(22-23-58(93)94)63(99)85-51(30-42-33-75-38-80-42)66(102)83-49(28-40-14-5-4-6-15-40)64(100)81-46(19-11-25-76-69(73)74)62(98)84-50(29-41-32-77-44-17-8-7-16-43(41)44)65(101)86-52(37-105-106-70(60,2)3)68(104)88-27-13-21-54(88)57(92)36-87-26-12-20-53(87)56(91)35-78-45(18-9-10-24-71)55(90)34-79-48(61(72)97)31-59(95)96/h4-8,14-17,32-33,38,45-54,60,77-79H,9-13,18-31,34-37,71H2,1-3H3,(H2,72,97)(H,75,80)(H,81,100)(H,82,103)(H,83,102)(H,84,98)(H,85,99)(H,86,101)(H,93,94)(H,95,96)(H4,73,74,76)/t45-,46-,47+,48-,49-,50+,51-,52?,53-,54-,60?/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131878
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-D-Cys]-Pro-Pro-...)Show SMILES CC(=O)C1CSSCC(NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47?,49-,50-,51+,52-,53-,54+,55-,56?,57-,58-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131881
(Ac-c[Cys-Glu-Pro-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C67H94N16O16S2/c1-38(84)42-36-100-101-37-50(66(99)82-27-11-20-52(82)56(87)35-81-26-10-19-51(81)55(86)34-74-44(17-7-8-24-68)54(85)33-75-47(59(69)92)31-58(90)91)80-63(96)49(30-40-32-73-43-16-6-5-15-41(40)43)78-61(94)45(18-9-25-72-67(70)71)76-62(95)48(29-39-13-3-2-4-14-39)79-64(97)53-21-12-28-83(53)65(98)46(77-60(42)93)22-23-57(88)89/h2-6,13-16,32,42,44-53,73-75H,7-12,17-31,33-37,68H2,1H3,(H2,69,92)(H,76,95)(H,77,93)(H,78,94)(H,79,97)(H,80,96)(H,88,89)(H,90,91)(H4,70,71,72)/t42-,44-,45-,46+,47-,48-,49+,50+,51-,52-,53-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50001518
(CHEMBL2112603)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.76,100.108,85.93,52.56,37.39,26.28,wD:77.84,12.12,3.2,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49+,50+,51-,52+,53+,54-,55+,56-,57+,58+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50001519
(CHEMBL2111808)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:96.103,81.88,48.51,3.2,37.39,26.28,wD:8.71,73.79,12.12,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45-,46-,47+,48-,49-,50+,51-,52-,53-,54-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 5.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131881
(Ac-c[Cys-Glu-Pro-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C67H94N16O16S2/c1-38(84)42-36-100-101-37-50(66(99)82-27-11-20-52(82)56(87)35-81-26-10-19-51(81)55(86)34-74-44(17-7-8-24-68)54(85)33-75-47(59(69)92)31-58(90)91)80-63(96)49(30-40-32-73-43-16-6-5-15-41(40)43)78-61(94)45(18-9-25-72-67(70)71)76-62(95)48(29-39-13-3-2-4-14-39)79-64(97)53-21-12-28-83(53)65(98)46(77-60(42)93)22-23-57(88)89/h2-6,13-16,32,42,44-53,73-75H,7-12,17-31,33-37,68H2,1H3,(H2,69,92)(H,76,95)(H,77,93)(H,78,94)(H,79,97)(H,80,96)(H,88,89)(H,90,91)(H4,70,71,72)/t42-,44-,45-,46+,47-,48-,49+,50+,51-,52-,53-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50001519
(CHEMBL2111808)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:96.103,81.88,48.51,3.2,37.39,26.28,wD:8.71,73.79,12.12,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45-,46-,47+,48-,49-,50+,51-,52-,53-,54-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131872
(Ac-c[Asp-Glu-His-D-Phe-Arg-Trp-Lys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CC(=O)NCCCC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H101N19O17/c1-41(92)46-33-61(96)78-26-10-8-19-51(71(108)91-29-13-22-57(91)60(95)39-90-28-12-21-56(90)59(94)38-81-48(18-7-9-25-73)58(93)37-82-52(64(74)101)34-63(99)100)86-69(106)54(31-43-35-80-47-17-6-5-16-45(43)47)88-66(103)49(20-11-27-79-72(75)76)85-68(105)53(30-42-14-3-2-4-15-42)87-70(107)55(32-44-36-77-40-83-44)89-67(104)50(84-65(46)102)23-24-62(97)98/h2-6,14-17,35-36,40,46,48-57,80-82H,7-13,18-34,37-39,73H2,1H3,(H2,74,101)(H,77,83)(H,78,96)(H,84,102)(H,85,105)(H,86,106)(H,87,107)(H,88,103)(H,89,104)(H,97,98)(H,99,100)(H4,75,76,79)/t46-,48-,49-,50+,51+,52-,53-,54+,55-,56-,57-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131872
(Ac-c[Asp-Glu-His-D-Phe-Arg-Trp-Lys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CC(=O)NCCCC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H101N19O17/c1-41(92)46-33-61(96)78-26-10-8-19-51(71(108)91-29-13-22-57(91)60(95)39-90-28-12-21-56(90)59(94)38-81-48(18-7-9-25-73)58(93)37-82-52(64(74)101)34-63(99)100)86-69(106)54(31-43-35-80-47-17-6-5-16-45(43)47)88-66(103)49(20-11-27-79-72(75)76)85-68(105)53(30-42-14-3-2-4-15-42)87-70(107)55(32-44-36-77-40-83-44)89-67(104)50(84-65(46)102)23-24-62(97)98/h2-6,14-17,35-36,40,46,48-57,80-82H,7-13,18-34,37-39,73H2,1H3,(H2,74,101)(H,77,83)(H,78,96)(H,84,102)(H,85,105)(H,86,106)(H,87,107)(H,88,103)(H,89,104)(H,97,98)(H,99,100)(H4,75,76,79)/t46-,48-,49-,50+,51+,52-,53-,54+,55-,56-,57-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human Melanocortin 3 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131872
(Ac-c[Asp-Glu-His-D-Phe-Arg-Trp-Lys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CC(=O)NCCCC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H101N19O17/c1-41(92)46-33-61(96)78-26-10-8-19-51(71(108)91-29-13-22-57(91)60(95)39-90-28-12-21-56(90)59(94)38-81-48(18-7-9-25-73)58(93)37-82-52(64(74)101)34-63(99)100)86-69(106)54(31-43-35-80-47-17-6-5-16-45(43)47)88-66(103)49(20-11-27-79-72(75)76)85-68(105)53(30-42-14-3-2-4-15-42)87-70(107)55(32-44-36-77-40-83-44)89-67(104)50(84-65(46)102)23-24-62(97)98/h2-6,14-17,35-36,40,46,48-57,80-82H,7-13,18-34,37-39,73H2,1H3,(H2,74,101)(H,77,83)(H,78,96)(H,84,102)(H,85,105)(H,86,106)(H,87,107)(H,88,103)(H,89,104)(H,97,98)(H,99,100)(H4,75,76,79)/t46-,48-,49-,50+,51+,52-,53-,54+,55-,56-,57-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131878
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-D-Cys]-Pro-Pro-...)Show SMILES CC(=O)C1CSSCC(NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47?,49-,50-,51+,52-,53-,54+,55-,56?,57-,58-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131877
(Ac-c[Cys-Glu-Pro-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C71H96N16O16S2/c1-40(88)46-38-104-105-39-54(70(103)86-28-10-19-56(86)60(91)37-85-27-9-18-55(85)59(90)36-78-48(16-6-7-25-72)58(89)35-79-51(63(73)96)33-62(94)95)84-67(100)53(32-44-34-77-47-15-5-4-14-45(44)47)82-65(98)49(17-8-26-76-71(74)75)80-66(99)52(31-41-21-22-42-12-2-3-13-43(42)30-41)83-68(101)57-20-11-29-87(57)69(102)50(81-64(46)97)23-24-61(92)93/h2-5,12-15,21-22,30,34,46,48-57,77-79H,6-11,16-20,23-29,31-33,35-39,72H2,1H3,(H2,73,96)(H,80,99)(H,81,97)(H,82,98)(H,83,101)(H,84,100)(H,92,93)(H,94,95)(H4,74,75,76)/t46-,48-,49-,50+,51-,52-,53+,54+,55-,56-,57-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50001518
(CHEMBL2112603)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.76,100.108,85.93,52.56,37.39,26.28,wD:77.84,12.12,3.2,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49+,50+,51-,52+,53+,54-,55+,56-,57+,58+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131875
(Ac-c[Pen-Glu-His-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C70H98N18O16S2/c1-39(89)60-67(103)82-47(22-23-58(93)94)63(99)85-51(30-42-33-75-38-80-42)66(102)83-49(28-40-14-5-4-6-15-40)64(100)81-46(19-11-25-76-69(73)74)62(98)84-50(29-41-32-77-44-17-8-7-16-43(41)44)65(101)86-52(37-105-106-70(60,2)3)68(104)88-27-13-21-54(88)57(92)36-87-26-12-20-53(87)56(91)35-78-45(18-9-10-24-71)55(90)34-79-48(61(72)97)31-59(95)96/h4-8,14-17,32-33,38,45-54,60,77-79H,9-13,18-31,34-37,71H2,1-3H3,(H2,72,97)(H,75,80)(H,81,100)(H,82,103)(H,83,102)(H,84,98)(H,85,99)(H,86,101)(H,93,94)(H,95,96)(H4,73,74,76)/t45-,46-,47+,48-,49-,50+,51-,52?,53-,54-,60?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50001505
(CHEMBL2112604)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.71,96.103,81.88,48.51,37.39,26.28,wD:73.79,12.12,3.2,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45+,46+,47-,48+,49+,50-,51+,52-,53+,54+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131878
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-D-Cys]-Pro-Pro-...)Show SMILES CC(=O)C1CSSCC(NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47?,49-,50-,51+,52-,53-,54+,55-,56?,57-,58-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 4.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 4 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131877
(Ac-c[Cys-Glu-Pro-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C71H96N16O16S2/c1-40(88)46-38-104-105-39-54(70(103)86-28-10-19-56(86)60(91)37-85-27-9-18-55(85)59(90)36-78-48(16-6-7-25-72)58(89)35-79-51(63(73)96)33-62(94)95)84-67(100)53(32-44-34-77-47-15-5-4-14-45(44)47)82-65(98)49(17-8-26-76-71(74)75)80-66(99)52(31-41-21-22-42-12-2-3-13-43(42)30-41)83-68(101)57-20-11-29-87(57)69(102)50(81-64(46)97)23-24-61(92)93/h2-5,12-15,21-22,30,34,46,48-57,77-79H,6-11,16-20,23-29,31-33,35-39,72H2,1H3,(H2,73,96)(H,80,99)(H,81,97)(H,82,98)(H,83,101)(H,84,100)(H,92,93)(H,94,95)(H4,74,75,76)/t46-,48-,49-,50+,51-,52-,53+,54+,55-,56-,57-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 9.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Inhibition of human melanocortin 5 receptor |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50001518
(CHEMBL2112603)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.76,100.108,85.93,52.56,37.39,26.28,wD:77.84,12.12,3.2,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49+,50+,51-,52+,53+,54-,55+,56-,57+,58+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 880 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation (10e-10 to 10e-4 M) |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50001520
(CHEMBL2111807)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:100.108,85.93,52.56,3.2,37.39,26.28,wD:8.76,77.84,12.12,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49-,50-,51+,52-,53-,54+,55-,56-,57-,58-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 190 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131880
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C74H100N18O16S2/c1-41(93)64-71(107)86-51(23-24-62(97)98)67(103)89-55(32-46-35-79-40-84-46)70(106)87-53(30-42-21-22-43-13-4-5-14-44(43)29-42)68(104)85-50(18-10-26-80-73(77)78)66(102)88-54(31-45-34-81-48-16-7-6-15-47(45)48)69(105)90-56(39-109-110-74(64,2)3)72(108)92-28-12-20-58(92)61(96)38-91-27-11-19-57(91)60(95)37-82-49(17-8-9-25-75)59(94)36-83-52(65(76)101)33-63(99)100/h4-7,13-16,21-22,29,34-35,40,49-58,64,81-83H,8-12,17-20,23-28,30-33,36-39,75H2,1-3H3,(H2,76,101)(H,79,84)(H,85,104)(H,86,107)(H,87,106)(H,88,102)(H,89,103)(H,90,105)(H,97,98)(H,99,100)(H4,77,78,80)/t49-,50-,51+,52-,53-,54+,55-,56?,57-,58-,64?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131877
(Ac-c[Cys-Glu-Pro-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C71H96N16O16S2/c1-40(88)46-38-104-105-39-54(70(103)86-28-10-19-56(86)60(91)37-85-27-9-18-55(85)59(90)36-78-48(16-6-7-25-72)58(89)35-79-51(63(73)96)33-62(94)95)84-67(100)53(32-44-34-77-47-15-5-4-14-45(44)47)82-65(98)49(17-8-26-76-71(74)75)80-66(99)52(31-41-21-22-42-12-2-3-13-43(42)30-41)83-68(101)57-20-11-29-87(57)69(102)50(81-64(46)97)23-24-61(92)93/h2-5,12-15,21-22,30,34,46,48-57,77-79H,6-11,16-20,23-29,31-33,35-39,72H2,1H3,(H2,73,96)(H,80,99)(H,81,97)(H,82,98)(H,83,101)(H,84,100)(H,92,93)(H,94,95)(H4,74,75,76)/t46-,48-,49-,50+,51-,52-,53+,54+,55-,56-,57-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation (10e-10 to 10e-4 M) |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131872
(Ac-c[Asp-Glu-His-D-Phe-Arg-Trp-Lys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CC(=O)NCCCC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H101N19O17/c1-41(92)46-33-61(96)78-26-10-8-19-51(71(108)91-29-13-22-57(91)60(95)39-90-28-12-21-56(90)59(94)38-81-48(18-7-9-25-73)58(93)37-82-52(64(74)101)34-63(99)100)86-69(106)54(31-43-35-80-47-17-6-5-16-45(43)47)88-66(103)49(20-11-27-79-72(75)76)85-68(105)53(30-42-14-3-2-4-15-42)87-70(107)55(32-44-36-77-40-83-44)89-67(104)50(84-65(46)102)23-24-62(97)98/h2-6,14-17,35-36,40,46,48-57,80-82H,7-13,18-34,37-39,73H2,1H3,(H2,74,101)(H,77,83)(H,78,96)(H,84,102)(H,85,105)(H,86,106)(H,87,107)(H,88,103)(H,89,104)(H,97,98)(H,99,100)(H4,75,76,79)/t46-,48-,49-,50+,51+,52-,53-,54+,55-,56-,57-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50001505
(CHEMBL2112604)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.71,96.103,81.88,48.51,37.39,26.28,wD:73.79,12.12,3.2,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45+,46+,47-,48+,49+,50-,51+,52-,53+,54+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50001519
(CHEMBL2111808)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:96.103,81.88,48.51,3.2,37.39,26.28,wD:8.71,73.79,12.12,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45-,46-,47+,48-,49-,50+,51-,52-,53-,54-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131881
(Ac-c[Cys-Glu-Pro-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C67H94N16O16S2/c1-38(84)42-36-100-101-37-50(66(99)82-27-11-20-52(82)56(87)35-81-26-10-19-51(81)55(86)34-74-44(17-7-8-24-68)54(85)33-75-47(59(69)92)31-58(90)91)80-63(96)49(30-40-32-73-43-16-6-5-15-41(40)43)78-61(94)45(18-9-25-72-67(70)71)76-62(95)48(29-39-13-3-2-4-14-39)79-64(97)53-21-12-28-83(53)65(98)46(77-60(42)93)22-23-57(88)89/h2-6,13-16,32,42,44-53,73-75H,7-12,17-31,33-37,68H2,1H3,(H2,69,92)(H,76,95)(H,77,93)(H,78,94)(H,79,97)(H,80,96)(H,88,89)(H,90,91)(H4,70,71,72)/t42-,44-,45-,46+,47-,48-,49+,50+,51-,52-,53-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131881
(Ac-c[Cys-Glu-Pro-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C67H94N16O16S2/c1-38(84)42-36-100-101-37-50(66(99)82-27-11-20-52(82)56(87)35-81-26-10-19-51(81)55(86)34-74-44(17-7-8-24-68)54(85)33-75-47(59(69)92)31-58(90)91)80-63(96)49(30-40-32-73-43-16-6-5-15-41(40)43)78-61(94)45(18-9-25-72-67(70)71)76-62(95)48(29-39-13-3-2-4-14-39)79-64(97)53-21-12-28-83(53)65(98)46(77-60(42)93)22-23-57(88)89/h2-6,13-16,32,42,44-53,73-75H,7-12,17-31,33-37,68H2,1H3,(H2,69,92)(H,76,95)(H,77,93)(H,78,94)(H,79,97)(H,80,96)(H,88,89)(H,90,91)(H4,70,71,72)/t42-,44-,45-,46+,47-,48-,49+,50+,51-,52-,53-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 401 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131872
(Ac-c[Asp-Glu-His-D-Phe-Arg-Trp-Lys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CC(=O)NCCCC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H101N19O17/c1-41(92)46-33-61(96)78-26-10-8-19-51(71(108)91-29-13-22-57(91)60(95)39-90-28-12-21-56(90)59(94)38-81-48(18-7-9-25-73)58(93)37-82-52(64(74)101)34-63(99)100)86-69(106)54(31-43-35-80-47-17-6-5-16-45(43)47)88-66(103)49(20-11-27-79-72(75)76)85-68(105)53(30-42-14-3-2-4-15-42)87-70(107)55(32-44-36-77-40-83-44)89-67(104)50(84-65(46)102)23-24-62(97)98/h2-6,14-17,35-36,40,46,48-57,80-82H,7-13,18-34,37-39,73H2,1H3,(H2,74,101)(H,77,83)(H,78,96)(H,84,102)(H,85,105)(H,86,106)(H,87,107)(H,88,103)(H,89,104)(H,97,98)(H,99,100)(H4,75,76,79)/t46-,48-,49-,50+,51+,52-,53-,54+,55-,56-,57-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131875
(Ac-c[Pen-Glu-His-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C70H98N18O16S2/c1-39(89)60-67(103)82-47(22-23-58(93)94)63(99)85-51(30-42-33-75-38-80-42)66(102)83-49(28-40-14-5-4-6-15-40)64(100)81-46(19-11-25-76-69(73)74)62(98)84-50(29-41-32-77-44-17-8-7-16-43(41)44)65(101)86-52(37-105-106-70(60,2)3)68(104)88-27-13-21-54(88)57(92)36-87-26-12-20-53(87)56(91)35-78-45(18-9-10-24-71)55(90)34-79-48(61(72)97)31-59(95)96/h4-8,14-17,32-33,38,45-54,60,77-79H,9-13,18-31,34-37,71H2,1-3H3,(H2,72,97)(H,75,80)(H,81,100)(H,82,103)(H,83,102)(H,84,98)(H,85,99)(H,86,101)(H,93,94)(H,95,96)(H4,73,74,76)/t45-,46-,47+,48-,49-,50+,51-,52?,53-,54-,60?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50001518
(CHEMBL2112603)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.76,100.108,85.93,52.56,37.39,26.28,wD:77.84,12.12,3.2,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49+,50+,51-,52+,53+,54-,55+,56-,57+,58+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131878
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-D-Cys]-Pro-Pro-...)Show SMILES CC(=O)C1CSSCC(NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47?,49-,50-,51+,52-,53-,54+,55-,56?,57-,58-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM82411
(CAS_75921-69-6 | NDP-MSH)Show SMILES CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O |r,wU:66.68,55.56,45.45,111.116,4.4,14.23,wD:77.79,95.99,107.113,36.36,8.10,26.29,(-7.66,4.36,;-8.98,3.65,;-9.15,2.12,;-10.5,1.37,;-10.5,-.23,;-11.93,-.94,;-13.21,-.15,;-13.17,1.41,;-14.6,-.83,;-14.64,-2.37,;-13.43,-3.18,;-15.78,-.09,;-17.19,-.68,;-17.34,-2.22,;-18.55,.02,;-18.4,1.67,;-17.08,2.44,;-17.08,3.97,;-15.61,4.72,;-14.35,3.82,;-13,4.55,;-14.45,2.26,;-15.78,1.52,;-19.9,-.62,;-21.14,.17,;-21.14,1.73,;-22.53,-.62,;-22.53,-2.12,;-21.33,-2.88,;-23.81,.17,;-25.13,-.41,;-26.27,.45,;-25.2,-1.9,;-9.26,-1,;-9.3,-2.5,;-7.94,-.34,;-6.59,-1.15,;-6.59,-2.71,;-7.94,-3.46,;-7.94,-5,;-9.3,-5.6,;-6.63,-5.81,;-5.24,-.34,;-5.2,1.15,;-3.86,-1.11,;-2.57,-.23,;-2.57,1.26,;-1.19,2.05,;.1,1.47,;1.29,2.58,;.52,3.87,;-.97,3.65,;-1.19,-1,;-1.19,-2.5,;.1,-.3,;1.55,-1.15,;1.55,-2.65,;2.79,-3.4,;2.79,-4.89,;4.22,-5.7,;5.56,-4.89,;5.56,-3.4,;4.22,-2.65,;2.79,-.34,;2.79,1.2,;4.22,-1,;5.33,-.09,;5.29,1.47,;6.63,2.26,;6.53,3.82,;7.81,4.72,;7.81,6.13,;9.13,7.03,;6.46,6.92,;6.85,-.73,;7,-2.37,;8,.13,;9.35,-.41,;9.69,-2.07,;10.95,-2.71,;12.29,-1.9,;13.51,-2.99,;12.83,-4.36,;13.43,-5.81,;12.55,-7.03,;10.95,-6.77,;10.33,-5.43,;11.29,-4.21,;10.69,.41,;10.48,2.16,;12.04,-.41,;13.38,.3,;14.58,-.51,;14.47,-2.03,;15.99,.17,;17.25,-.68,;17.25,-2.26,;18.49,-3.08,;18.45,-4.57,;19.73,-5.55,;19.69,-7.03,;18.66,.02,;18.77,1.52,;20.01,-.68,;20.09,-2.22,;21.72,-2.54,;22.29,-1.11,;21.5,-.09,;21.78,1.47,;20.65,2.84,;23.32,1.64,;23.83,2.97,;23,4.19,;23.6,5.58,;21.5,4.04,;25.41,3.12,;26.03,4.44,;26.27,1.94,)| Show InChI InChI=1S/C78H111N21O19/c1-5-6-19-52(91-75(116)61(41-101)97-72(113)57(34-46-24-26-49(103)27-25-46)94-74(115)60(40-100)88-44(4)102)68(109)92-54(28-29-64(105)106)70(111)96-59(36-48-38-83-42-87-48)73(114)93-56(33-45-16-8-7-9-17-45)71(112)90-53(22-14-31-84-78(81)82)69(110)95-58(35-47-37-85-51-20-11-10-18-50(47)51)67(108)86-39-63(104)89-55(21-12-13-30-79)77(118)99-32-15-23-62(99)76(117)98-65(43(2)3)66(80)107/h7-11,16-18,20,24-27,37-38,42-43,52-62,65,85,100-101,103H,5-6,12-15,19,21-23,28-36,39-41,79H2,1-4H3,(H2,80,107)(H,83,87)(H,86,108)(H,88,102)(H,89,104)(H,90,112)(H,91,116)(H,92,109)(H,93,114)(H,94,115)(H,95,110)(H,96,111)(H,97,113)(H,98,117)(H,105,106)(H4,81,82,84)/t52-,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,65-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131875
(Ac-c[Pen-Glu-His-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C70H98N18O16S2/c1-39(89)60-67(103)82-47(22-23-58(93)94)63(99)85-51(30-42-33-75-38-80-42)66(102)83-49(28-40-14-5-4-6-15-40)64(100)81-46(19-11-25-76-69(73)74)62(98)84-50(29-41-32-77-44-17-8-7-16-43(41)44)65(101)86-52(37-105-106-70(60,2)3)68(104)88-27-13-21-54(88)57(92)36-87-26-12-20-53(87)56(91)35-78-45(18-9-10-24-71)55(90)34-79-48(61(72)97)31-59(95)96/h4-8,14-17,32-33,38,45-54,60,77-79H,9-13,18-31,34-37,71H2,1-3H3,(H2,72,97)(H,75,80)(H,81,100)(H,82,103)(H,83,102)(H,84,98)(H,85,99)(H,86,101)(H,93,94)(H,95,96)(H4,73,74,76)/t45-,46-,47+,48-,49-,50+,51-,52?,53-,54-,60?/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 6.30 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50001518
(CHEMBL2112603)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.76,100.108,85.93,52.56,37.39,26.28,wD:77.84,12.12,3.2,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49+,50+,51-,52+,53+,54-,55+,56-,57+,58+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50001520
(CHEMBL2111807)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:100.108,85.93,52.56,3.2,37.39,26.28,wD:8.76,77.84,12.12,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49-,50-,51+,52-,53-,54+,55-,56-,57-,58-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 6.10 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131875
(Ac-c[Pen-Glu-His-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C70H98N18O16S2/c1-39(89)60-67(103)82-47(22-23-58(93)94)63(99)85-51(30-42-33-75-38-80-42)66(102)83-49(28-40-14-5-4-6-15-40)64(100)81-46(19-11-25-76-69(73)74)62(98)84-50(29-41-32-77-44-17-8-7-16-43(41)44)65(101)86-52(37-105-106-70(60,2)3)68(104)88-27-13-21-54(88)57(92)36-87-26-12-20-53(87)56(91)35-78-45(18-9-10-24-71)55(90)34-79-48(61(72)97)31-59(95)96/h4-8,14-17,32-33,38,45-54,60,77-79H,9-13,18-31,34-37,71H2,1-3H3,(H2,72,97)(H,75,80)(H,81,100)(H,82,103)(H,83,102)(H,84,98)(H,85,99)(H,86,101)(H,93,94)(H,95,96)(H4,73,74,76)/t45-,46-,47+,48-,49-,50+,51-,52?,53-,54-,60?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50001519
(CHEMBL2111808)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:96.103,81.88,48.51,3.2,37.39,26.28,wD:8.71,73.79,12.12,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45-,46-,47+,48-,49-,50+,51-,52-,53-,54-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50001505
(CHEMBL2112604)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.71,96.103,81.88,48.51,37.39,26.28,wD:73.79,12.12,3.2,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45+,46+,47-,48+,49+,50-,51+,52-,53+,54+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50029747
((4S)-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-[({[(2S...)Show SMILES CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O Show InChI InChI=1S/C77H109N21O19S/c1-42(2)64(65(79)106)97-75(116)61-20-13-30-98(61)76(117)54(18-10-11-28-78)88-62(103)38-85-66(107)57(34-46-36-84-50-17-9-8-16-49(46)50)94-67(108)51(19-12-29-83-77(80)81)89-70(111)55(32-44-14-6-5-7-15-44)92-72(113)58(35-47-37-82-41-86-47)95-68(109)52(25-26-63(104)105)90-69(110)53(27-31-118-4)91-74(115)60(40-100)96-71(112)56(33-45-21-23-48(102)24-22-45)93-73(114)59(39-99)87-43(3)101/h5-9,14-17,21-24,36-37,41-42,51-61,64,84,99-100,102H,10-13,18-20,25-35,38-40,78H2,1-4H3,(H2,79,106)(H,82,86)(H,85,107)(H,87,101)(H,88,103)(H,89,111)(H,90,110)(H,91,115)(H,92,113)(H,93,114)(H,94,108)(H,95,109)(H,96,112)(H,97,116)(H,104,105)(H4,80,81,83)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,64-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 6.70 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50131880
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C74H100N18O16S2/c1-41(93)64-71(107)86-51(23-24-62(97)98)67(103)89-55(32-46-35-79-40-84-46)70(106)87-53(30-42-21-22-43-13-4-5-14-44(43)29-42)68(104)85-50(18-10-26-80-73(77)78)66(102)88-54(31-45-34-81-48-16-7-6-15-47(45)48)69(105)90-56(39-109-110-74(64,2)3)72(108)92-28-12-20-58(92)61(96)38-91-27-11-19-57(91)60(95)37-82-49(17-8-9-25-75)59(94)36-83-52(65(76)101)33-63(99)100/h4-7,13-16,21-22,29,34-35,40,49-58,64,81-83H,8-12,17-20,23-28,30-33,36-39,75H2,1-3H3,(H2,76,101)(H,79,84)(H,85,104)(H,86,107)(H,87,106)(H,88,102)(H,89,103)(H,90,105)(H,97,98)(H,99,100)(H4,77,78,80)/t49-,50-,51+,52-,53-,54+,55-,56?,57-,58-,64?/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131880
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)C1C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NC(CSSC1(C)C)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C74H100N18O16S2/c1-41(93)64-71(107)86-51(23-24-62(97)98)67(103)89-55(32-46-35-79-40-84-46)70(106)87-53(30-42-21-22-43-13-4-5-14-44(43)29-42)68(104)85-50(18-10-26-80-73(77)78)66(102)88-54(31-45-34-81-48-16-7-6-15-47(45)48)69(105)90-56(39-109-110-74(64,2)3)72(108)92-28-12-20-58(92)61(96)38-91-27-11-19-57(91)60(95)37-82-49(17-8-9-25-75)59(94)36-83-52(65(76)101)33-63(99)100/h4-7,13-16,21-22,29,34-35,40,49-58,64,81-83H,8-12,17-20,23-28,30-33,36-39,75H2,1-3H3,(H2,76,101)(H,79,84)(H,85,104)(H,86,107)(H,87,106)(H,88,102)(H,89,103)(H,90,105)(H,97,98)(H,99,100)(H4,77,78,80)/t49-,50-,51+,52-,53-,54+,55-,56?,57-,58-,64?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM82411
(CAS_75921-69-6 | NDP-MSH)Show SMILES CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O |r,wU:66.68,55.56,45.45,111.116,4.4,14.23,wD:77.79,95.99,107.113,36.36,8.10,26.29,(-7.66,4.36,;-8.98,3.65,;-9.15,2.12,;-10.5,1.37,;-10.5,-.23,;-11.93,-.94,;-13.21,-.15,;-13.17,1.41,;-14.6,-.83,;-14.64,-2.37,;-13.43,-3.18,;-15.78,-.09,;-17.19,-.68,;-17.34,-2.22,;-18.55,.02,;-18.4,1.67,;-17.08,2.44,;-17.08,3.97,;-15.61,4.72,;-14.35,3.82,;-13,4.55,;-14.45,2.26,;-15.78,1.52,;-19.9,-.62,;-21.14,.17,;-21.14,1.73,;-22.53,-.62,;-22.53,-2.12,;-21.33,-2.88,;-23.81,.17,;-25.13,-.41,;-26.27,.45,;-25.2,-1.9,;-9.26,-1,;-9.3,-2.5,;-7.94,-.34,;-6.59,-1.15,;-6.59,-2.71,;-7.94,-3.46,;-7.94,-5,;-9.3,-5.6,;-6.63,-5.81,;-5.24,-.34,;-5.2,1.15,;-3.86,-1.11,;-2.57,-.23,;-2.57,1.26,;-1.19,2.05,;.1,1.47,;1.29,2.58,;.52,3.87,;-.97,3.65,;-1.19,-1,;-1.19,-2.5,;.1,-.3,;1.55,-1.15,;1.55,-2.65,;2.79,-3.4,;2.79,-4.89,;4.22,-5.7,;5.56,-4.89,;5.56,-3.4,;4.22,-2.65,;2.79,-.34,;2.79,1.2,;4.22,-1,;5.33,-.09,;5.29,1.47,;6.63,2.26,;6.53,3.82,;7.81,4.72,;7.81,6.13,;9.13,7.03,;6.46,6.92,;6.85,-.73,;7,-2.37,;8,.13,;9.35,-.41,;9.69,-2.07,;10.95,-2.71,;12.29,-1.9,;13.51,-2.99,;12.83,-4.36,;13.43,-5.81,;12.55,-7.03,;10.95,-6.77,;10.33,-5.43,;11.29,-4.21,;10.69,.41,;10.48,2.16,;12.04,-.41,;13.38,.3,;14.58,-.51,;14.47,-2.03,;15.99,.17,;17.25,-.68,;17.25,-2.26,;18.49,-3.08,;18.45,-4.57,;19.73,-5.55,;19.69,-7.03,;18.66,.02,;18.77,1.52,;20.01,-.68,;20.09,-2.22,;21.72,-2.54,;22.29,-1.11,;21.5,-.09,;21.78,1.47,;20.65,2.84,;23.32,1.64,;23.83,2.97,;23,4.19,;23.6,5.58,;21.5,4.04,;25.41,3.12,;26.03,4.44,;26.27,1.94,)| Show InChI InChI=1S/C78H111N21O19/c1-5-6-19-52(91-75(116)61(41-101)97-72(113)57(34-46-24-26-49(103)27-25-46)94-74(115)60(40-100)88-44(4)102)68(109)92-54(28-29-64(105)106)70(111)96-59(36-48-38-83-42-87-48)73(114)93-56(33-45-16-8-7-9-17-45)71(112)90-53(22-14-31-84-78(81)82)69(110)95-58(35-47-37-85-51-20-11-10-18-50(47)51)67(108)86-39-63(104)89-55(21-12-13-30-79)77(118)99-32-15-23-62(99)76(117)98-65(43(2)3)66(80)107/h7-11,16-18,20,24-27,37-38,42-43,52-62,65,85,100-101,103H,5-6,12-15,19,21-23,28-36,39-41,79H2,1-4H3,(H2,80,107)(H,83,87)(H,86,108)(H,88,102)(H,89,104)(H,90,112)(H,91,116)(H,92,109)(H,93,114)(H,94,115)(H,95,110)(H,96,111)(H,97,113)(H,98,117)(H,105,106)(H4,81,82,84)/t52-,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,65-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM82411
(CAS_75921-69-6 | NDP-MSH)Show SMILES CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O |r,wU:66.68,55.56,45.45,111.116,4.4,14.23,wD:77.79,95.99,107.113,36.36,8.10,26.29,(-7.66,4.36,;-8.98,3.65,;-9.15,2.12,;-10.5,1.37,;-10.5,-.23,;-11.93,-.94,;-13.21,-.15,;-13.17,1.41,;-14.6,-.83,;-14.64,-2.37,;-13.43,-3.18,;-15.78,-.09,;-17.19,-.68,;-17.34,-2.22,;-18.55,.02,;-18.4,1.67,;-17.08,2.44,;-17.08,3.97,;-15.61,4.72,;-14.35,3.82,;-13,4.55,;-14.45,2.26,;-15.78,1.52,;-19.9,-.62,;-21.14,.17,;-21.14,1.73,;-22.53,-.62,;-22.53,-2.12,;-21.33,-2.88,;-23.81,.17,;-25.13,-.41,;-26.27,.45,;-25.2,-1.9,;-9.26,-1,;-9.3,-2.5,;-7.94,-.34,;-6.59,-1.15,;-6.59,-2.71,;-7.94,-3.46,;-7.94,-5,;-9.3,-5.6,;-6.63,-5.81,;-5.24,-.34,;-5.2,1.15,;-3.86,-1.11,;-2.57,-.23,;-2.57,1.26,;-1.19,2.05,;.1,1.47,;1.29,2.58,;.52,3.87,;-.97,3.65,;-1.19,-1,;-1.19,-2.5,;.1,-.3,;1.55,-1.15,;1.55,-2.65,;2.79,-3.4,;2.79,-4.89,;4.22,-5.7,;5.56,-4.89,;5.56,-3.4,;4.22,-2.65,;2.79,-.34,;2.79,1.2,;4.22,-1,;5.33,-.09,;5.29,1.47,;6.63,2.26,;6.53,3.82,;7.81,4.72,;7.81,6.13,;9.13,7.03,;6.46,6.92,;6.85,-.73,;7,-2.37,;8,.13,;9.35,-.41,;9.69,-2.07,;10.95,-2.71,;12.29,-1.9,;13.51,-2.99,;12.83,-4.36,;13.43,-5.81,;12.55,-7.03,;10.95,-6.77,;10.33,-5.43,;11.29,-4.21,;10.69,.41,;10.48,2.16,;12.04,-.41,;13.38,.3,;14.58,-.51,;14.47,-2.03,;15.99,.17,;17.25,-.68,;17.25,-2.26,;18.49,-3.08,;18.45,-4.57,;19.73,-5.55,;19.69,-7.03,;18.66,.02,;18.77,1.52,;20.01,-.68,;20.09,-2.22,;21.72,-2.54,;22.29,-1.11,;21.5,-.09,;21.78,1.47,;20.65,2.84,;23.32,1.64,;23.83,2.97,;23,4.19,;23.6,5.58,;21.5,4.04,;25.41,3.12,;26.03,4.44,;26.27,1.94,)| Show InChI InChI=1S/C78H111N21O19/c1-5-6-19-52(91-75(116)61(41-101)97-72(113)57(34-46-24-26-49(103)27-25-46)94-74(115)60(40-100)88-44(4)102)68(109)92-54(28-29-64(105)106)70(111)96-59(36-48-38-83-42-87-48)73(114)93-56(33-45-16-8-7-9-17-45)71(112)90-53(22-14-31-84-78(81)82)69(110)95-58(35-47-37-85-51-20-11-10-18-50(47)51)67(108)86-39-63(104)89-55(21-12-13-30-79)77(118)99-32-15-23-62(99)76(117)98-65(43(2)3)66(80)107/h7-11,16-18,20,24-27,37-38,42-43,52-62,65,85,100-101,103H,5-6,12-15,19,21-23,28-36,39-41,79H2,1-4H3,(H2,80,107)(H,83,87)(H,86,108)(H,88,102)(H,89,104)(H,90,112)(H,91,116)(H,92,109)(H,93,114)(H,94,115)(H,95,110)(H,96,111)(H,97,113)(H,98,117)(H,105,106)(H4,81,82,84)/t52-,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,65-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50029747
((4S)-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-[({[(2S...)Show SMILES CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O Show InChI InChI=1S/C77H109N21O19S/c1-42(2)64(65(79)106)97-75(116)61-20-13-30-98(61)76(117)54(18-10-11-28-78)88-62(103)38-85-66(107)57(34-46-36-84-50-17-9-8-16-49(46)50)94-67(108)51(19-12-29-83-77(80)81)89-70(111)55(32-44-14-6-5-7-15-44)92-72(113)58(35-47-37-82-41-86-47)95-68(109)52(25-26-63(104)105)90-69(110)53(27-31-118-4)91-74(115)60(40-100)96-71(112)56(33-45-21-23-48(102)24-22-45)93-73(114)59(39-99)87-43(3)101/h5-9,14-17,21-24,36-37,41-42,51-61,64,84,99-100,102H,10-13,18-20,25-35,38-40,78H2,1-4H3,(H2,79,106)(H,82,86)(H,85,107)(H,87,101)(H,88,103)(H,89,111)(H,90,110)(H,91,115)(H,92,113)(H,93,114)(H,94,108)(H,95,109)(H,96,112)(H,97,116)(H,104,105)(H4,80,81,83)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,64-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131872
(Ac-c[Asp-Glu-His-D-Phe-Arg-Trp-Lys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CC(=O)NCCCC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H101N19O17/c1-41(92)46-33-61(96)78-26-10-8-19-51(71(108)91-29-13-22-57(91)60(95)39-90-28-12-21-56(90)59(94)38-81-48(18-7-9-25-73)58(93)37-82-52(64(74)101)34-63(99)100)86-69(106)54(31-43-35-80-47-17-6-5-16-45(43)47)88-66(103)49(20-11-27-79-72(75)76)85-68(105)53(30-42-14-3-2-4-15-42)87-70(107)55(32-44-36-77-40-83-44)89-67(104)50(84-65(46)102)23-24-62(97)98/h2-6,14-17,35-36,40,46,48-57,80-82H,7-13,18-34,37-39,73H2,1H3,(H2,74,101)(H,77,83)(H,78,96)(H,84,102)(H,85,105)(H,86,106)(H,87,107)(H,88,103)(H,89,104)(H,97,98)(H,99,100)(H4,75,76,79)/t46-,48-,49-,50+,51+,52-,53-,54+,55-,56-,57-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131877
(Ac-c[Cys-Glu-Pro-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C71H96N16O16S2/c1-40(88)46-38-104-105-39-54(70(103)86-28-10-19-56(86)60(91)37-85-27-9-18-55(85)59(90)36-78-48(16-6-7-25-72)58(89)35-79-51(63(73)96)33-62(94)95)84-67(100)53(32-44-34-77-47-15-5-4-14-45(44)47)82-65(98)49(17-8-26-76-71(74)75)80-66(99)52(31-41-21-22-42-12-2-3-13-43(42)30-41)83-68(101)57-20-11-29-87(57)69(102)50(81-64(46)97)23-24-61(92)93/h2-5,12-15,21-22,30,34,46,48-57,77-79H,6-11,16-20,23-29,31-33,35-39,72H2,1H3,(H2,73,96)(H,80,99)(H,81,97)(H,82,98)(H,83,101)(H,84,100)(H,92,93)(H,94,95)(H4,74,75,76)/t46-,48-,49-,50+,51-,52-,53+,54+,55-,56-,57-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50131878
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-D-Cys]-Pro-Pro-...)Show SMILES CC(=O)C1CSSCC(NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47?,49-,50-,51+,52-,53-,54+,55-,56?,57-,58-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM50001519
(CHEMBL2111808)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:96.103,81.88,48.51,3.2,37.39,26.28,wD:8.71,73.79,12.12,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45-,46-,47+,48-,49-,50+,51-,52-,53-,54-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131878
(Ac-c[Cys-Glu-His-D-Nal(2')-Arg-Trp-D-Cys]-Pro-Pro-...)Show SMILES CC(=O)C1CSSCC(NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47?,49-,50-,51+,52-,53-,54+,55-,56?,57-,58-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131877
(Ac-c[Cys-Glu-Pro-D-Nal(2')-Arg-Trp-Cys]-Pro-Pro-Ly...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C71H96N16O16S2/c1-40(88)46-38-104-105-39-54(70(103)86-28-10-19-56(86)60(91)37-85-27-9-18-55(85)59(90)36-78-48(16-6-7-25-72)58(89)35-79-51(63(73)96)33-62(94)95)84-67(100)53(32-44-34-77-47-15-5-4-14-45(44)47)82-65(98)49(17-8-26-76-71(74)75)80-66(99)52(31-41-21-22-42-12-2-3-13-43(42)30-41)83-68(101)57-20-11-29-87(57)69(102)50(81-64(46)97)23-24-61(92)93/h2-5,12-15,21-22,30,34,46,48-57,77-79H,6-11,16-20,23-29,31-33,35-39,72H2,1H3,(H2,73,96)(H,80,99)(H,81,97)(H,82,98)(H,83,101)(H,84,100)(H,92,93)(H,94,95)(H4,74,75,76)/t46-,48-,49-,50+,51-,52-,53+,54+,55-,56-,57-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50001505
(CHEMBL2112604)Show SMILES CC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:8.71,96.103,81.88,48.51,37.39,26.28,wD:73.79,12.12,3.2,86.92,58.62,(-2.26,-11.08,;-3.22,-9.89,;-4.74,-10.12,;-2.66,-8.39,;-1.17,-8.79,;.38,-8.72,;1.85,-8.24,;3.13,-7.37,;4.21,-6.27,;4.77,-4.8,;5.02,-3.27,;6.56,-3.3,;4.84,-1.74,;6.34,-1.35,;7.83,-1.75,;8.11,-3.25,;9.65,-3.46,;10.3,-2.06,;11.78,-1.62,;12.13,-.12,;11,.95,;9.53,.49,;9.18,-1,;4.26,-.29,;3.32,.93,;4.4,2.02,;2.08,1.84,;2.81,3.19,;4.35,3.22,;5.1,4.59,;6.64,4.62,;7.39,5.97,;8.93,6,;6.59,7.3,;.63,2.38,;-.9,2.52,;-.98,4.06,;-2.43,2.24,;-2.91,3.71,;-2.51,5.21,;-3.61,6.3,;-3.22,7.79,;-1.74,8.18,;-.63,7.12,;-1.02,5.62,;-3.82,1.56,;-4.97,.54,;-6.14,1.54,;-5.81,-.76,;-7.21,-.12,;-7.35,1.42,;-6.18,2.44,;-6.8,3.87,;-8.33,3.73,;-8.68,2.22,;-6.25,-2.24,;-6.28,-3.79,;-7.82,-3.96,;-5.9,-5.29,;-7.33,-5.87,;-8.56,-4.91,;-9.99,-5.5,;-11.2,-4.55,;-10.2,-7.03,;-5.13,-6.62,;-4.03,-7.69,;-4.94,-8.95,;5.43,-7.03,;4.41,-8.09,;5.82,-8.51,;4.8,-9.53,;5.45,-10.82,;6.87,-10.61,;6.89,-9.27,;7.99,-8.53,;8,-7.19,;9.16,-9.16,;10.51,-8.39,;9.48,-7.38,;10.12,-6.08,;11.56,-6.29,;11.56,-7.64,;12.67,-8.37,;12.67,-9.7,;13.83,-7.75,;14.96,-8.46,;16.02,-9.23,;16.02,-10.57,;17.18,-11.22,;17.18,-12.55,;18.32,-13.22,;18.32,-14.54,;17.12,-8.48,;17.13,-7.13,;18.3,-9.09,;19.64,-8.34,;20.69,-7.58,;20.69,-6.24,;21.85,-5.57,;23.12,-5.92,;21.85,-4.24,;21.8,-8.3,;21.71,-9.65,;22.99,-7.72,)| Show InChI InChI=1S/C68H94N18O16S2/c1-38(87)43-35-103-104-36-52(67(102)86-25-11-19-54(86)57(90)34-85-24-10-18-53(85)56(89)33-76-45(16-7-8-22-69)55(88)32-77-48(60(70)95)29-59(93)94)84-65(100)50(27-40-30-75-44-15-6-5-14-42(40)44)82-62(97)46(17-9-23-74-68(71)72)80-64(99)49(26-39-12-3-2-4-13-39)81-66(101)51(28-41-31-73-37-78-41)83-63(98)47(79-61(43)96)20-21-58(91)92/h2-6,12-15,30-31,37,43,45-54,75-77H,7-11,16-29,32-36,69H2,1H3,(H2,70,95)(H,73,78)(H,79,96)(H,80,99)(H,81,101)(H,82,97)(H,83,98)(H,84,100)(H,91,92)(H,93,94)(H4,71,72,74)/t43-,45+,46+,47-,48+,49+,50-,51+,52-,53+,54+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50131881
(Ac-c[Cys-Glu-Pro-D-Phe-Arg-Trp-Cys]-Pro-Pro-Lys-As...)Show SMILES CC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O Show InChI InChI=1S/C67H94N16O16S2/c1-38(84)42-36-100-101-37-50(66(99)82-27-11-20-52(82)56(87)35-81-26-10-19-51(81)55(86)34-74-44(17-7-8-24-68)54(85)33-75-47(59(69)92)31-58(90)91)80-63(96)49(30-40-32-73-43-16-6-5-15-41(40)43)78-61(94)45(18-9-25-72-67(70)71)76-62(95)48(29-39-13-3-2-4-14-39)79-64(97)53-21-12-28-83(53)65(98)46(77-60(42)93)22-23-57(88)89/h2-6,13-16,32,42,44-53,73-75H,7-12,17-31,33-37,68H2,1H3,(H2,69,92)(H,76,95)(H,77,93)(H,78,94)(H,79,97)(H,80,96)(H,88,89)(H,90,91)(H4,70,71,72)/t42-,44-,45-,46+,47-,48-,49+,50+,51-,52-,53-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 380 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation (10e-10 to 10e-4 M) |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 5
(Homo sapiens (Human)) | BDBM50029747
((4S)-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-[({[(2S...)Show SMILES CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O Show InChI InChI=1S/C77H109N21O19S/c1-42(2)64(65(79)106)97-75(116)61-20-13-30-98(61)76(117)54(18-10-11-28-78)88-62(103)38-85-66(107)57(34-46-36-84-50-17-9-8-16-49(46)50)94-67(108)51(19-12-29-83-77(80)81)89-70(111)55(32-44-14-6-5-7-15-44)92-72(113)58(35-47-37-82-41-86-47)95-68(109)52(25-26-63(104)105)90-69(110)53(27-31-118-4)91-74(115)60(40-100)96-71(112)56(33-45-21-23-48(102)24-22-45)93-73(114)59(39-99)87-43(3)101/h5-9,14-17,21-24,36-37,41-42,51-61,64,84,99-100,102H,10-13,18-20,25-35,38-40,78H2,1-4H3,(H2,79,106)(H,82,86)(H,85,107)(H,87,101)(H,88,103)(H,89,111)(H,90,110)(H,91,115)(H,92,113)(H,93,114)(H,94,108)(H,95,109)(H,96,112)(H,97,116)(H,104,105)(H4,80,81,83)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,64-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 8.10 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Melanocortin receptor 3
(Homo sapiens (Human)) | BDBM50001520
(CHEMBL2111807)Show SMILES CC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](CCC(O)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)CN1CCC[C@H]1C(=O)CN[C@@H](CCCCN)C(=O)CN[C@@H](CC(O)=O)C(N)=O |wU:100.108,85.93,52.56,3.2,37.39,26.28,wD:8.76,77.84,12.12,90.97,62.67,(-3.08,-11.89,;-4.04,-10.69,;-5.56,-10.93,;-3.48,-9.19,;-1.99,-9.59,;-.44,-9.53,;1.04,-9.05,;2.31,-8.18,;3.32,-7.01,;3.96,-5.59,;4.21,-4.07,;5.75,-4.11,;4.03,-2.53,;5.52,-2.16,;7.01,-2.55,;7.93,-3.79,;9.39,-3.3,;9.37,-1.75,;10.5,-.71,;10.16,.79,;8.68,1.25,;7.55,.2,;7.9,-1.29,;3.44,-1.11,;2.5,.12,;3.58,1.21,;1.26,1.03,;1.99,2.38,;3.54,2.42,;4.28,3.78,;5.83,3.82,;6.57,5.18,;8.12,5.2,;5.78,6.51,;-.19,1.58,;-1.72,1.72,;-1.8,3.26,;-3.25,1.44,;-3.73,2.91,;-3.33,4.41,;-1.84,4.83,;-1.45,6.31,;-2.56,7.4,;-2.16,8.89,;-3.26,9.98,;-4.76,9.54,;-5.14,8.06,;-4.04,6.99,;-4.43,5.49,;-4.64,.76,;-5.79,-.26,;-6.96,.74,;-6.63,-1.57,;-8.03,-.92,;-8.17,.62,;-7,1.64,;-7.63,3.06,;-9.15,2.92,;-9.5,1.42,;-7.07,-3.05,;-7.1,-4.59,;-8.64,-4.77,;-6.72,-6.08,;-8.15,-6.67,;-9.38,-5.72,;-10.81,-6.31,;-12.02,-5.36,;-11.02,-7.83,;-5.95,-7.43,;-4.85,-8.5,;-5.76,-9.75,;4.61,-7.83,;3.6,-8.89,;5.01,-9.31,;3.98,-10.33,;4.63,-11.64,;6.06,-11.42,;6.07,-10.08,;7.17,-9.33,;7.18,-8,;8.35,-9.96,;9.7,-9.21,;8.67,-8.19,;9.31,-6.88,;10.75,-7.09,;10.75,-8.44,;11.85,-9.18,;11.85,-10.51,;13.02,-8.56,;14.14,-9.26,;15.21,-10.03,;15.21,-11.36,;16.36,-12.03,;16.36,-13.36,;17.51,-14.03,;17.51,-15.35,;16.31,-9.28,;16.32,-7.94,;17.48,-9.91,;18.83,-9.14,;19.88,-8.37,;19.88,-7.04,;21.04,-6.38,;22.31,-6.71,;21.04,-5.05,;20.99,-9.12,;20.9,-10.45,;22.18,-8.54,)| Show InChI InChI=1S/C72H96N18O16S2/c1-40(91)47-37-107-108-38-56(71(106)90-26-10-18-58(90)61(94)36-89-25-9-17-57(89)60(93)35-80-49(15-6-7-23-73)59(92)34-81-52(64(74)99)31-63(97)98)88-69(104)54(29-44-32-79-48-14-5-4-13-46(44)48)86-66(101)50(16-8-24-78-72(75)76)84-68(103)53(28-41-19-20-42-11-2-3-12-43(42)27-41)85-70(105)55(30-45-33-77-39-82-45)87-67(102)51(83-65(47)100)21-22-62(95)96/h2-5,11-14,19-20,27,32-33,39,47,49-58,79-81H,6-10,15-18,21-26,28-31,34-38,73H2,1H3,(H2,74,99)(H,77,82)(H,83,100)(H,84,103)(H,85,105)(H,86,101)(H,87,102)(H,88,104)(H,95,96)(H,97,98)(H4,75,76,78)/t47-,49-,50-,51+,52-,53-,54+,55-,56-,57-,58-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
University of Arizona
Curated by ChEMBL
| Assay Description
Effective concentration of peptide at 50% maximal cAMP generation |
J Med Chem 46: 3728-33 (2003)
Article DOI: 10.1021/jm030111j
BindingDB Entry DOI: 10.7270/Q2125TDT |
More data for this
Ligand-Target Pair | |
Search and Browse
